About TeraPore
TeraPore is a Healthcare company based in San Francisco (United States) founded in 2013 by Rachel Dorin. Developer of bioseparation solutions for therapeutics and novel biologics. TeraPore has raised $19.53 million across 12 funding rounds from investors including Cornell University, Wilson Sonsini Goodrich & Rosati and Entegris. The company has 16 employees. Its chief executive, as recorded, is Rachel Dorin. TeraPore offers products and services including IsoBlock® VF. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Filtration. Its competitors include Cytosorbents, Alkymos and Vanguard Scientific Systems; 3 of its 3 listed competitors have raised funding.
Company details
TeraPore was founded in 2013 in San Francisco, United States, within the biotechnology sector. Bioseparation solutions are provided for therapeutics and novel biologics through operations centered on filtration technologies. IsoBlock filters are produced via a proprietary Intelligent Membrane platform, enabling viral clearance and elevated filtration capacity in virus removal processes. The companys activities support downstream bioprocessing needs in the life sciences industry.
- Headquarters San Francisco, United States
- Employees 16
- Founders Rachel Dorin
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website terapore.com
- Social LinkedIn
- Total Equity Funding$19.53M (USD)
in 12 rounds
- Latest Funding Round$10M (USD), Series B
Mar 2023
- InvestorsCornell University
& 9 more
- Employee Count16
Products & Services of TeraPore
TeraPore offers a comprehensive portfolio of products and services, including IsoBlock® VF.
Engineered for viral clearance in therapeutic proteins and biologics.
Funding Insights of TeraPore
TeraPore has successfully raised a total of $19.53M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19.53M
- Total Rounds 12
- Last Round Series B — $10M
- First Round $149,907
(Jul 2013)
- Investors Count 10
Latest 10 of 12 funding rounds of TeraPore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $10M | Series B | – | Anzu Partners | |
| Mar 2018 | $6M | Series A | – | Anzu Partners | |
| Dec 2017 | $1.77M | Seed | – | – | – |
| Jun 2016 | $1.76M | Seed | – | – | – |
| Mar 2016 | Grant | – | – | ||
| Jan 2016 | $150,000 | Grant | – | – | |
| Apr 2015 | $224,929 | Grant | – | – | |
| Jan 2015 | $149,997 | Grant | – | – | |
| Sep 2014 | $733,619 | Grant | – | – | |
| Aug 2014 | Seed | – | – |
10 investors in total: 10 institutional.
Investors in TeraPore
TeraPore has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Cornell University, Wilson Sonsini Goodrich & Rosati and Entegris.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in industrial and life sciences technology companies. | anzupartners.com | Washington, Dc, United States | ||
Venture capital firm investing in technology and healthcare sectors. | 2000 | artiman.com | ||
Seed-stage investments are targeted by 43North in startups. | 43north.org | Buffalo, United States | ||
RA Capital is engaged in evidence-based investing in healthcare and life sciences. | 2004 | racap.com | Boston, United States | |
Materials handling solutions are supplied for semiconductor manufacturing processes. | 1966 | entegris.com | Billerica, United States | |
Provider of legal services to technology and life science companies | 1961 | wsgr.com | Palo Alto, United States | |
| youngstartup.com | ||||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Undergraduate, graduate, and professional programs are offered in diverse fields. | 1865 | cornell.edu | United States |
Investor details for TeraPore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TeraPore
13 people are tracked at TeraPore (11 in leadership, 2 in team); the tracked headcount is 16.
| Name | Role | Group |
|---|---|---|
Rachel Dorin | Founder & CEO | Leadership |
Sean Cusack | Senior Director Of Engineering And Manufacturing | Leadership |
Mani Krishnan | President And COO | Leadership |
Tim Simpson | Facilities Manager/safety Director | Leadership |
Olivier Blachier | Director | Leadership |
Jack Wilson | Vp, Product | Leadership |
Ajay Joshi | Senior Director Of Quality | Leadership |
Yury Agroskin | Head Of Operations And Engineering | Leadership |
David Michael | Director | Leadership |
Daniele Gerion | Vice President Of Research & Development | Leadership |
Sylvie Chavanne | Vice President Operations | Leadership |
Jae Cho | Fellow | Team |
Shane Glover | Process Specialist | Team |
Complete people profiles for TeraPore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TeraPore
3 dated milestones of TeraPore across 10 years, from founding to its latest funding, stage changes and deals.
- Founded TeraPore is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Series B, of $10.0M.
Competitors of TeraPore
TeraPore has 3 listed competitors in our database, 3 of them funded. They include Cytosorbents, Alkymos and Vanguard Scientific Systems.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cytosorbents.com | 1997 | Monmouth Junction, United States | $22.04M | 198 | Hemoperfusion technology is developed to remove toxins from blood. | |
| alkymos.com | 2006 | Lexington, United States | $643,500 | Specializes in chelators and chelator-based filtration devices. | ||
| vanguardscientific.com | 2015 | Oregon, United States | $2.65M | Creates innovative equipment for botanical extraction industries. |
Detailed competitors of TeraPore
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as TeraPore (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TeraPore
TeraPore was founded in 2013.
TeraPore is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Rachel Dorin is the CEO of TeraPore, as recorded in our data. They have also founded this company.
TeraPore is a funded company, having raised a total of $19.53M across 12 funding rounds to date.
TeraPore has 16 employees.
TeraPore was founded in 2013 in San Francisco, United States, within the biotechnology sector. Bioseparation solutions are provided for therapeutics and novel biologics through operations centered on filtration technologies. IsoBlock filters are produced via a proprietary Intelligent Membrane platform, enabling viral clearance and elevated filtration capacity in virus removal processes. The companys activities support downstream bioprocessing needs in the life sciences industry.
TeraPore's top competitors include Cytosorbents, Alkymos and Vanguard Scientific Systems.
TeraPore offers IsoBlock® VF.
TeraPore has 10 investors. Key investors include Cornell University, Wilson Sonsini Goodrich & Rosati, Entegris, HHS, and RA Capital.